Patient and Genetic Counselor Perceptions of In-person Versus Telephone Genetic Counseling for Hereditary Breast/ovarian Cancer
Overview
Authors
Affiliations
Telephone genetic counseling (TC) for high-risk women interested in BRCA1/2 testing has been shown to yield positive outcomes comparable to usual care (UC; in-person) genetic counseling. However, little is known about how genetic counselors perceive the delivery of these alternate forms of genetic counseling. As part of a randomized trial of TC versus UC, genetic counselors completed a 5-item genetic counselor process questionnaire (GCQ) assessing key elements of pre-test sessions (information delivery, emotional support, addressing questions and concerns, tailoring of session, and facilitation of decision-making) with the 479 female participants (TC, N = 236; UC, N = 243). The GCQ scores did not differ for TC vs. UC sessions (t (477) = 0.11, p = 0.910). However, multivariate analysis showed that participant race/ethnicity significantly predicted genetic counselor perceptions (β = 0.172, p < 0.001) in that the GCQ scores were lower for minorities in TC and UC. Exploratory analyses suggested that GCQ scores may be associated with patient preference for UC versus TC (t (79) = 2.21, p = 0.030). Additionally, we found that genetic counselor ratings of session effectiveness were generally concordant with patient perceptions of the session. These data indicate that genetic counselors perceive that key components of TC can be delivered as effectively as UC, and that these elements may contribute to specific aspects of patient satisfaction. However, undefined process differences may be present which account for lower counselor perceptions about the effectiveness of their sessions with minority women (i.e., those other than non-Hispanic Whites). We discuss other potential clinical and research implications of our findings.
Perspectives on Telemedicine Visits Reported by Patients With Cancer.
Doshi S, Charvadeh Y, Seier K, Bange E, Daly B, Lipitz-Snyderman A JAMA Netw Open. 2024; 7(11):e2445363.
PMID: 39546309 PMC: 11568458. DOI: 10.1001/jamanetworkopen.2024.45363.
Transforming patient-centered cancer care using telehealth: the MATCHES Center.
Bange E, Daly R, Lipitz-Snyderman A, Kuperman G, Polubriaginof F, Liebertz C J Natl Cancer Inst Monogr. 2024; 2024(64):76-82.
PMID: 38924792 PMC: 11207685. DOI: 10.1093/jncimonographs/lgae004.
Bange E, Li Y, Kumar P, Doucette A, Gabriel P, Parikh R Cancer. 2023; 130(4):636-644.
PMID: 37987207 PMC: 10922036. DOI: 10.1002/cncr.35116.
Chu A, Chung C, Hue S, Chung B Front Genet. 2023; 14:1239817.
PMID: 37600657 PMC: 10435751. DOI: 10.3389/fgene.2023.1239817.
Zang B, Helms M, Besch L, Kalmbach N, Stegen S, Blohmer J Arch Gynecol Obstet. 2022; 307(5):1585-1592.
PMID: 36307613 PMC: 10110675. DOI: 10.1007/s00404-022-06819-3.